Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations

المصدر: Nasdaq GlobeNewswire / 25 أبريل 2022 06:00:01   America/Chicago